This data supports the product's launch in 2014 as the first approved GLP-1 weight loss drug
GLP-1 medications act on receptors in the brain and gut to increase feelings of fullness, decrease cravings, slow stomach emptying, and improve blood sugar regulation
management Early empiric therapy may be considered
It means that obesity is a chronic condition that requires ongoing management
A competent prescriber understands obesity as a disease, the full medication toolkit, the controlled-substance compliance phentermine requires, the side-effect and lean-mass considerations semaglutide brings, and the program-level judgment that decides when to use one, the other, or both in sequence
Berberine can also help your body respond to insulin better, but not likely as well as metformin